More...Snapshot
Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a “peakless” profile (according to the insulin glargine package insert).
The Asia-Pacific In
Table of Content
1 Industry Overview
1.1 Insulin Glargine Industry
1.1.1 Overview
1.1.2 Development of Insulin Glargine
1.2 Market Segment
1.2.1 By Product Type
1.2.2 By Application
1.3 Asia-Pacific Overview
2 Major Companies List
2.1 Sanofi-Aventis (Company Profile, Products & Services, Sales Data etc.)
2.2 Ganlee (Company Profile, Products & Se